Press release
Transcatheter Heart Valve Replacement Devices Market Set for Robust Growth Through 2030, Driven by Technological Breakthroughs and FDA Approvals | DelveInsight
Transcatheter Heart Valve Replacement Devices Market Insights, Competitive Landscape and Market Forecast-2030
DelveInsight's "Transcatheter Heart Valve Replacement Devices Market Insights, Competitive Landscape and Market Forecast-2030 [https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers an in-depth understanding of the transcatheter heart valve replacement devices market, historical and forecasted market trends across North America, Europe, Asia-Pacific, and the Rest of the World. The report comprehensively evaluates the current treatment landscape, emerging technologies, market share of individual products, and market forecasts through 2030, providing crucial insights for stakeholders in the cardiovascular device therapeutic area.
Market Outlook
According to DelveInsight's analysis, the transcatheter heart valve replacement devices market is projected to grow substantially with an impressive 13.75% CAGR during the forecast period from 2024 to 2030, driven by the growing prevalence of cardiovascular disorders, increasing product developmental activities, rising sedentary lifestyle and lifestyle-associated disorders, and increasing preference for minimally invasive surgeries.
North America is expected to dominate the overall transcatheter heart valve replacement devices market, attributed to high instances of myocardial infarction, heart valve diseases, and associated risk factors, combined with significant advancements in product development and regulatory approvals, the presence of key market players, and the availability of well-established advanced healthcare infrastructure. DelveInsight's analysis reveals that 2.5% of the Canadian population had heart valve diseases in 2022, increasing significantly after age 65 and reaching up to 13% after age 75, with projections indicating 1.5 million Canadians over 65 will have heart valve disease by 2040.
Download the Transcatheter Heart Valve Replacement Devices Market report to understand which factors are driving the market @ Transcatheter Heart Valve Replacement Devices Market Trends [https://www.delveinsight.com/sample-request/transcatheter-heart-valve-replacement-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
Transcatheter Heart Valve Replacement Devices Patient Pool
According to DelveInsight's estimates, approximately 640 million people were living with heart and circulatory diseases worldwide in 2022, highlighting the substantial patient population requiring cardiovascular interventions. Furthermore, the World Health Organization reported a prevalence of 9 million cases of calcific aortic valve stenosis globally, representing a significant target market for transcatheter heart valve replacement technologies. The report also indicates that 805,000 people in the US experience myocardial infarction annually, with nearly 47% of Americans having at least one major heart disease risk factor, including high blood cholesterol, high blood pressure, and smoking.
Discover evolving trends in the Transcatheter Heart Valve Replacement Devices patient pool forecasts @ Transcatheter Heart Valve Replacement Devices Patient Pool Analysis [https://www.delveinsight.com/sample-request/transcatheter-heart-valve-replacement-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
Top Performing Market Segments
The DelveInsight report breaks down the transcatheter heart valve replacement devices market into key segments for easier understanding. It categorizes products into three types: Transcatheter Aortic Valve Replacement, Mitral Valve Replacement, and Pulmonary Valve Replacement. The market is also divided by application, including conditions like aortic and mitral valve stenosis or regurgitation. This clear segmentation helps in understanding treatment trends and how these devices are used in different healthcare settings.
Among all these segmentations, the transcatheter aortic valve replacement segment continues to demonstrate strong performance due to its transfemoral approach, which allows access to the aorta through the femoral artery in the groin, resulting in smaller incisions and less surgical trauma. This approach leads to significant benefits, including shorter recovery times, reduced post-operative pain, decreased hospital stays, fewer wound complications, and better prosthesis outcomes. Advanced imaging and device technology improvements have enhanced valve placement precision during procedures, leading to superior overall results.
Recent Developments
The transcatheter heart valve replacement landscape has experienced several important regulatory approvals and product launches in the first half of 2025. This reflects rapid innovation extending beyond aortic stenosis into mitral and tricuspid indications, as well as expanded patient populations and new device technologies.
In May 2025, the FDA approved a groundbreaking transcatheter mitral valve replacement system for patients with severe mitral annular calcification, based on the results of the SUMMIT trial. The FDA also expanded the SAPIEN 3 TAVR platform to include asymptomatic patients with severe aortic stenosis, following the EARLY TAVR trial, within the same month.
Additionally, Medtronic's Evolut Pro+ and FX systems received CE Mark approval in Europe in May 2025, allowing for "redo" TAVR procedures within failed transcatheter valves. Abbott's Tendyne Trademark TMVR system was also approved by the FDA in May 2025 for patients suffering from mitral valve disease and severe mitral annular calcification.
In June 2025, India's CDSCO approved Foldax's TRIA Trademark polymer mitral heart valve, making it the first commercially available polymer-based transcatheter valve. Earlier, in January 2025, Abbott launched its Navitor Trademark Vision next-generation TAVI system in India for patients with symptomatic severe aortic stenosis.
Discover recent advancements in the Transcatheter Heart Valve Replacement Devices landscape @ Transcatheter Heart Valve Replacement Devices Recent Developments [https://www.delveinsight.com/sample-request/transcatheter-heart-valve-replacement-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
Transcatheter Heart Valve Replacement Devices Competitive Landscape
The transcatheter heart valve replacement devices market is highly competitive [https://www.delveinsight.com/sample-request/transcatheter-heart-valve-replacement-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr], with major players including Medtronic, Boston Scientific Corporation, Bracco SpA, Edwards Lifesciences, Meril Lifesciences, JenaValve Technologies Inc., Venus Medtech (Hangzhou) Inc., Abbott, Bluesail Medical Co., Ltd., Braile Biomedica, CryoLife, Inc., SMT, Peijia Medical Limited, P+F Products + Features GmbH, and Livanova Plc, all advancing innovative technologies through robust research and development initiatives and strategic regulatory approvals.
Future Outlook
Looking ahead, the transcatheter heart valve replacement devices market is expected to witness continued innovation driven by enhanced device technology, improved patient outcomes, and expanding procedural adoption. While significant progress has been made in minimally invasive approaches, challenges remain in addressing complex anatomical variations, optimizing long-term durability, and improving accessibility across diverse patient populations. The market continues to evolve with technological advancements, focusing on enhanced delivery systems, improved valve designs, and expanded indications, positioning the industry for sustained growth through 2030.
Table of Contents
1. Transcatheter Heart Valve Replacement Market Report Introduction
2. Transcatheter Heart Valve Replacement Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Transcatheter Heart Valve Replacement Market Key Factors Analysis
6. Transcatheter Heart Valve Replacement Market Porter's Five Forces Analysis
7. Transcatheter Heart Valve Replacement Market Assessment
8. Transcatheter Heart Valve Replacement Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=transcatheter-heart-valve-replacement-devices-market-set-for-robust-growth-through-2030-driven-by-technological-breakthroughs-and-fda-approvals-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transcatheter Heart Valve Replacement Devices Market Set for Robust Growth Through 2030, Driven by Technological Breakthroughs and FDA Approvals | DelveInsight here
News-ID: 4098441 • Views: …
More Releases from ABNewswire
Cell and Gene Therapy in Parkinson's Disease Market to Experience Notable Growth …
The Key Cell and Gene Therapy in Parkinson's Disease Companies in the market include - Prevail Therapeutics (Eli Lilly), MeiraGTx, Hope Biosciences, and others.
DelveInsight's "Cell and Gene Therapy in Parkinson's Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cell and Gene Therapy in Parkinson's Disease, historical and forecasted epidemiology as well as the Cell and Gene Therapy in Parkinson's Disease market trends in the…
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Polycythemia Vera pipeline constitutes 8+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsigh …
The Key Myelofibrosis Companies in the market include - Lynk Pharmaceuticals, Samus Therapeutics, Taiga Biotechnologies, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Inc., Keros Therapeutics, Inc., Galecto Biotech AB, Actuate Therapeutics Inc., Karyopharm Therapeutics, AbbVie, Sierra Oncology, and others.
DelveInsight's "Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology as well as the Myelofibrosis market trends in the United States, EU4 (Germany, Spain,…
Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Obser …
The Key Asthma Companies in the market inlcude - GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharmaceuticals, Inc., AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharmaceuticals, Genentech Research, Roche, Suzhou Connect Biopharmaceuticals, Avalo Therapeutics, 4D Pharma plc, Regeneron Pharmaceuticals, RAPT Therapeutics, Inc., Incyte Corporation, Areteia Therapeutics, Suzhou Connect Biopharmaceuticals, Ltd., Cumberland Pharmaceuticals, Pulmatrix Inc., and others.
DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Asthma, historical and…
More Releases for Valve
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
The availability of abundant natural resources, such as petroleum and shale gas, in Australia is expected to provide profitable opportunities for the Australia pressure safety valve market. Moreover, the government‐™s initiative to encourage offshore exploration of minerals deposits could further boost the business opportunities for market players in Australia. The presence of a wide oil & gas distribution network continues to provide a steady stream of revenue to market players;…
Control Valve Market by Region - North America, Latin America, Europe, Japan, AP …
Increasing penetration of automation across several industrial verticals has fuelled the demand for components that regulate pressure, temperature and other elements effectively. Manufacturers are advancing their capabilities in developing control valves for the future industrial demands. New designs are being incorporated to increase the efficiency of control valves in enabling a direct control of the flow rate, and in processing the information on liquid level, temperature and pressure.
According to Fact.MR’s…
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
Australian pressure safety valve market size is expected to reach $65.38 million by 2025 from $52.12 million in 2017, growing at a CAGR of 2.88% during the forecast period (2018–2025). Pressure safety valves (pressure relief valves) are specially designed valves that regulate the surge in pressure within the pressure systems, which otherwise could hinder industrial processes. The valves have outlets that guide the additional flow of fluids or gases, which…
Control Valve Market Analysis Report by Region - North America, Latin America, E …
Fact.MRs’ latest forecast study assesses that the global control valve market will expand steadily during the forecast period, 2017-2026. Increasing industrialization and growing use of pneumatics in mechanical processes will drive the adoption of control valves to a considerable extent. The global control valve market will register expansion at a 5.4% CAGR in terms of volume over, the forecast period. By the end of 2026, control valves worth over US$ 15.5 Bn…
Bleed Valve Market 2017-Eaton, Weir Group, KSB, Mahle, Mogas, Alfa Laval, Nihon …
Apex Research, recently published a detailed market research study focused on the "Bleed Valve Market" across the global, regional and country level. The report provides 360° analysis of "Bleed Valve Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bleed Valve industry, and estimates the future trend of Bleed Valve market…
Global Plug Valves Market: Yuandong Valve, Yuanda Valve, Weir, Walworth, Zhengqu …
Global Market Study Evaluate on Plug Valves Industry by Type, Manufacturers, Application, Type, and Regions, Forecast up to 2022
The scope of the global Plug Valves market report is:
This report offers a comprehensive evaluation of the Plug Valves market. It does so by in-depth qualitative insights, historical Plug Valves market data, and verifiable projections about global Plug Valves market size. The projections featured in the Plug Valves market report have been…
